The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy

Overview of attention for article published in Frontiers in oncology, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 9,792 followers.

New research: The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy: The epidermal growth factor receptor (EGFR) is a therapeutic target in head and neck… https://t.co/T3i7J

10 Sep 2021

Reply Repost Favourite

Sommige vormen van #kanker kunnen resistent worden aan nieuwe kankergeneesmiddelen. Maar we onderzoeken met spoed hoe we die resistentie met een combinatiebehandeling kunnen vermijden. Net gepubliceerd @FrontOncology door @CORE_UAntwerp @UAntwerpen 👨‍🔬👩‍🔬🔬

10 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.